ESAB Corporation Investor Presentation November 2022

ESAB is a leader in mission-critical technologies for medical and advanced industrial markets with approximately $857M in annual revenue. The company operates across medical and industrial segments with adjusted EBITDA of ~$183M, serving a $6B addressable market growing at 5-7% annually.